Free tool
FAERS Monitor: Singulair
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021409 or its brand name (Singulair, Montelukast Sodium). Reports on generic versions are filed under their own applications.
Reports
123,347
Serious
74,156
60% of reports
Hospitalization
33,110
Death reported
5,007
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- asthma15,205
- dyspnoea15,084
- drug ineffective9,422
- cough9,228
- fatigue8,837
- headache8,389
- wheezing7,763
- pneumonia7,167
- nausea6,920
- pain6,688
- malaise5,385
- dizziness4,955
- diarrhoea4,945
- anxiety4,881
- off label use4,790
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,613 |
| 2005 | 1,707 |
| 2006 | 1,908 |
| 2007 | 2,149 |
| 2008 | 3,591 |
| 2009 | 3,025 |
| 2010 | 3,506 |
| 2011 | 3,559 |
| 2012 | 4,455 |
| 2013 | 5,045 |
| 2014 | 4,415 |
| 2015 | 5,984 |
| 2016 | 8,194 |
| 2017 | 6,321 |
| 2018 | 7,118 |
| 2019 | 8,121 |
| 2020 | 8,598 |
| 2021 | 7,917 |
| 2022 | 7,807 |
| 2023 | 6,744 |
| 2024 | 7,752 |
| 2025 | 7,713 |
| 2026 | 6,101 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,930,812 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| asthmaSignal | 15,205 | 26.3 | 25.9 | 322,673 |
| wheezingSignal | 7,763 | 25.5 | 24.9 | 159,466 |
| coughSignal | 9,228 | 5.8 | 5.7 | 35,644 |
| dyspnoeaSignal | 15,084 | 4.6 | 4.6 | 43,089 |
| pneumoniaSignal | 7,167 | 3.8 | 3.8 | 14,931 |
| anxietySignal | 4,881 | 3.0 | 2.9 | 6,301 |
| headacheSignal | 8,389 | 2.3 | 2.3 | 6,260 |
| malaiseSignal | 5,385 | 2.1 | 2.1 | 3,159 |
| fatigue | 8,837 | 1.9 | 1.9 | 4,173 |
| pain | 6,688 | 1.9 | 1.8 | 2,738 |
| dizziness | 4,955 | 1.7 | 1.7 | 1,451 |
| nausea | 6,920 | 1.5 | 1.5 | 1,169 |
| diarrhoea | 4,945 | 1.3 | 1.3 | 368 |
| drug ineffective | 9,422 | 1.2 | 1.2 | 398 |
| off label use | 4,790 | 0.9 | 0.9 | 24 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.